ICI plus chemotherapy prolonged survival over ICI alone in patients with previously treated advanced NSCLC

Mao, SQ; Zhou, F; Liu, YW; Yang, S; Chen, B; Xu, J; Wu, FY; Li, XF; Zhao, C; Wang, WY; Liu, Q; Yu, XF; Jia, KY; Shao, CC; Zhou, CC; Gao, GH; Ren, SX

Gao, GH; Ren, SX (通讯作者)，Tongji Univ, Shanghai Pulm Hosp, Thorac Canc Inst, Dept Med Oncol,Sch Med, 507 Zheng Min Rd, Shanghai 200433, Peoples R China.

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022; 71 (1): 219

Abstract

Objectives Immune checkpoint inhibitors (ICI) monotherapy was standard of care in second-line treatment of patients with advance non-small cell lung c......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索